Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 14 of the 18 sources its claims cite were checked for support.

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21

Open access
Wang, Haidong, Paulson, Katherine R, Pease, Spencer A, Watson, Stefanie, Comfort, Haley, Zheng, Peng, Aravkin, Aleksandr Y, Bisignano, Catherine, Barber, Ryan M, Alam, Tahiya, Fuller, John E, May, Erin A, Jones, Darwin Phan, Frisch, Meghan E, Abbafati, Cristiana, Adolph, Christopher, Allorant, Adrien, Amlag, Joanne O, Bang-Jensen, Bree, Bertolacci, Gregory J, Bloom, Sabina S, Carter, Austin, Castro, Emma, Chakrabarti, Suman, Chattopadhyay, Jhilik, Cogen, Rebecca M, Collins, James K, Cooperrider, Kimberly, Dai, Xiaochen, Dangel, William James, Daoud, Farah, Dapper, Carolyn, Deen, Amanda, Duncan, Bruce B, Erickson, Megan, Ewald, Samuel B, Fedosseeva, Tatiana, Ferrari, Alize J, Frostad, Joseph Jon, Fullman, Nancy, Gallagher, John, Gamkrelidze, Amiran, Guo, Gaorui, He, Jiawei, Helak, Monika, Henry, Nathaniel J, Hulland, Erin N, Huntley, Bethany M, Kereselidze, Maia, Lazzar-Atwood, Alice, LeGrand, Kate E, Lindstrom, Akiaja, Linebarger, Emily, Lotufo, Paulo A, Lozano, Rafael, Magistro, Beatrice, Malta, Deborah Carvalho, Månsson, Johan, Mantilla Herrera, Ana M, Marinho, Fatima, Mirkuzie, Alemnesh H, Misganaw, Awoke Temesgen, Monasta, Lorenzo, Naik, Paulami, Nomura, Shuhei, O'Brien, Edward G, O'Halloran, James Kevin, Olana, Latera Tesfaye, Ostroff, Samuel M, Penberthy, Louise, Reiner Jr, Robert C, Reinke, Grace, Ribeiro, Antonio Luiz P, Santomauro, Damian Francesco, Schmidt, Maria Inês, Shaw, David H, Sheena, Brittney S, Sholokhov, Aleksei, Skhvitaridze, Natia, Sorensen, Reed J D, Spurlock, Emma Elizabeth, Syailendrawati, Ruri, Topor-Madry, Roman, Troeger, Christopher E, Walcott, Rebecca, Walker, Ally, Wiysonge, Charles Shey, Worku, Nahom Alemseged, Zigler, Bethany, Pigott, David M, Naghavi, Mohsen, Mokdad, Ali H, Lim, Stephen S, Hay, Simon I, Gakidou, Emmanuela, Murray, Christopher J L · 2022 · The Lancet

Abstract

BACKGROUND: Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from the COVID-19 pandemic in 191 countries and territories, and 252 subnational units for selected countries, from Jan 1, 2020, to Dec 31, 2021. METHODS: All-cause mortality reports were collected for 74 countries and territories and 266 subnational locations (including 31 locations in low-income and middle-income countries) that had reported either weekly or monthly deaths from all causes during the pandemic in 2020 and 2021, and for up to 11 year previously. In addition, we obtained excess mortality data for 12 states in India. Excess mortality over time was calculated as observed mortality, after excluding data from periods affected by late registration and anomalies such as heat waves, minus expected mortality. Six models were used to estimate expected mortality; final estimates of expected mortality were based on an ensemble of these models. Ensemble weights were based on root mean squared errors derived from an out-of-sample predictive validity test. As mortality records are incomplete worldwide, we built a statistical model that predicted the excess mortality rate for locations and periods where all-cause mortality data were not available. We used least absolute shrinkage and selection operator (LASSO) regression as a variable selection mechanism and selected 15 covariates, including both covariates pertaining to the COVID-19 pandemic, such as seroprevalence, and to background population health metrics, such as the Healthcare Access and Quality Index, with direction of effects on excess mortality concordant with a meta-analysis by the US Centers for Disease Control and Prevention. With the selected best model, we ran a prediction process using 100 draws for each covariate and 100 draws of estimated coefficients and residuals, estimated from the regressions run at the draw level using draw-level input data on both excess mortality and covariates. Mean values and 95% uncertainty intervals were then generated at national, regional, and global levels. Out-of-sample predictive validity testing was done on the basis of our final model specification. FINDINGS: Although reported COVID-19 deaths between Jan 1, 2020, and Dec 31, 2021, totalled 5·94 million worldwide, we estimate that 18·2 million (95% uncertainty interval 17·1-19·6) people died worldwide because of the COVID-19 pandemic (as measured by excess mortality) over that period. The global all-age rate of excess mortality due to the COVID-19 pandemic was 120·3 deaths (113·1-129·3) per 100 000 of the population, and excess mortality rate exceeded 300 deaths per 100 000 of the population in 21 countries. The number of excess deaths due to COVID-19 was largest in the regions of south Asia, north Africa and the Middle East, and eastern Europe. At the country level, the highest numbers of cumulative excess deaths due to COVID-19 were estimated in India (4·07 million [3·71-4·36]), the USA (1·13 million [1·08-1·18]), Russia (1·07 million [1·06-1·08]), Mexico (798 000 [741 000-867 000]), Brazil (792 000 [730 000-847 000]), Indonesia (736 000 [594 000-955 000]), and Pakistan (664 000 [498 000-847 000]). Among these countries, the excess mortality rate was highest in Russia (374·6 deaths [369·7-378·4] per 100 000) and Mexico (325·1 [301·6-353·3] per 100 000), and was similar in Brazil (186·9 [172·2-199·8] per 100 000) and the USA (179·3 [170·7-187·5] per 100 000). INTERPRETATION: The full impact of the pandemic has been much greater than what is indicated by reported deaths due to COVID-19 alone. Strengthening death registration systems around the world, long understood to be crucial to global public health strategy, is necessary for improved monitoring of this pandemic and future pandemics. In addition, further research is warranted to help distinguish the proportion of excess mortality that was directly caused by SARS-CoV-2 infection and the changes in causes of death as an indirect consequence of the pandemic. FUNDING: Bill & Melinda Gates Foundation, J Stanton, T Gillespie, and J and E Nordstrom.

Overview

CoChat Summary

## TL;DR

This study estimates that the COVID-19 pandemic caused 18·2 million excess deaths worldwide from Jan 1, 2020 to Dec 31, 2021, far above the 5·94 million reported COVID-19 deaths. The burden was highly uneven across countries and regions, with especially high excess mortality in south Asia, north Africa and the Middle East, and eastern Europe.

## Key findings

  • Worldwide, the authors estimated 18·2 million excess deaths due to the pandemic (95% UI 17·1–19·6), about 3·07 times the 5·94 million reported COVID-19 deaths.
  • The global all-age excess mortality rate was 120·3 deaths per 100 000 population (113·1–129·3), and it exceeded 300 per 100 000 in 21 countries.
  • The largest cumulative excess death counts were estimated in India (4·07 million [3·71–4·36]), the USA (1·13 million [1·08–1·18]), and Russia (1·07 million [1·06–1·08]); these seven countries accounted for more than half of global excess deaths.
  • Among those high-burden countries, excess mortality rates were highest in Russia (374·6 per 100 000 [369·7–378·4]) and Mexico (325·1 [301·6–353·3]); Bolivia had the highest country-level excess mortality rate overall at 734·9 per 100 000 (594·1–879·2).

## Methods

  • Systematic analysis of excess mortality for Jan 1, 2020 to Dec 31, 2021 across 191 countries and territories and 252 subnational units for selected countries.
  • The study used all-cause mortality data from 74 countries and territories and 266 subnational locations, plus empirical excess mortality data for 12 states in India and provinces of South Africa.
  • Excess mortality was estimated by correcting reported mortality for late registration, anomalies such as heat waves, and under-registration, then subtracting ensemble-model predictions of expected mortality; for places without time-detailed all-cause mortality, a statistical model using 15 selected covariates predicted excess mortality.
  • The authors used six models in an ensemble for expected mortality, LASSO regression for covariate selection, and out-of-sample predictive validity testing; they propagated uncertainty with 100 draws.

## Limitations

  • The paper states that different modeling strategies were needed depending on data availability, and that direct measurement would be preferable to modelled excess mortality for places without all-cause mortality data.
  • The authors state they excluded the most recent weeks and months in 2021 because late registration can take 20 weeks or longer, and they note there is subjectivity in choosing the exclusion window.
  • The paper states that it estimated cumulative excess mortality rather than weekly or monthly excess mortality because reporting lags could make time-detailed ratios unstable.
  • Evident from the text: excess mortality is not decomposed into direct SARS-CoV-2 deaths versus indirect pandemic effects, and the authors say available cause-of-death data were too sparse to do this robustly.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)02796-3

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Late registration in all-cause mortality and its effect on computed excess mortality over time, USA Reported COVID-19 deaths (coloured lines) and estimated number of excess deaths due to the COVID-19 pandemic (dashed line) by week from series of weekly mortality data reported by calendar week from October, 2020, to February, 2022. The gap between the first calendar week during which mortality for a past week was reported and the subsequent reported levels indicates the gradual process by which completeness of reported deaths increases over time. Lines below 0 indicate reported deaths below the expected deaths value.
Figure 1 Late registration in all-cause mortality and its effect on computed excess mortality over time, USA Reported COVID-19 deaths (coloured lines) and estimated number of excess deaths due to the COVID-19 pandemic (dashed line) by week from series of weekly mortality data reported by calendar week from October, 2020, to February, 2022. The gap between the first calendar week during which mortality for a past week was reported and the subsequent reported levels indicates the gradual process by which completeness of reported deaths increases over time. Lines below 0 indicate reported deaths below the expected deaths value.CC BY · PubMed Central
Figure 2 Global distribution of estimated excess mortality rate due to the COVID-19 pandemic, for the cumulative period 2020–21
Figure 2 Global distribution of estimated excess mortality rate due to the COVID-19 pandemic, for the cumulative period 2020–21CC BY · PubMed Central
Figure 3 Stacked bar chart of regional distribution of excess deaths for 2020–21 The distribution of excess deaths by GBD super-region for the cumulative period. Countries labelled on each stacked bar are the three countries with the highest estimated excess deaths within the GBD super-region. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
Figure 3 Stacked bar chart of regional distribution of excess deaths for 2020–21 The distribution of excess deaths by GBD super-region for the cumulative period. Countries labelled on each stacked bar are the three countries with the highest estimated excess deaths within the GBD super-region. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.CC BY · PubMed Central
Figure 4 Global distribution of the ratio between estimated excess mortality rate due to the COVID-19 pandemic and reported COVID-19 mortality rate, for the cumulative period 2020–21
Figure 4 Global distribution of the ratio between estimated excess mortality rate due to the COVID-19 pandemic and reported COVID-19 mortality rate, for the cumulative period 2020–21CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 8 Not valid · 2 Not checked · 121 Own results and interpretations

91 more claims · 2 with their cited sources checked

Create a free account to see all 135 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 29

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 32 references

Cited by

See all 2,069

Metadata

Authors
Wang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., Aravkin, A. Y., Bisignano, C., Barber, R. M., Alam, T., Fuller, J. E., May, E. A., Jones, D. P., Frisch, M. E., Abbafati, C., Adolph, C., Allorant, A., Amlag, J. O., Bang-Jensen, B., Bertolacci, G. J., Bloom, S. S., Carter, A., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., Cooperrider, K., Dai, X., Dangel, W. J., Daoud, F., Dapper, C., Deen, A., Duncan, B. B., Erickson, M., Ewald, S. B., Fedosseeva, T., Ferrari, A. J., Frostad, J. J., Fullman, N., Gallagher, J., Gamkrelidze, A., Guo, G., He, J., Helak, M., Henry, N. J., Hulland, E. N., Huntley, B. M., Kereselidze, M., Lazzar-Atwood, A., LeGrand, K. E., Lindstrom, A., Linebarger, E., Lotufo, P. A., Lozano, R., Magistro, B., Malta, D. C., Månsson, J., Mantilla Herrera, A. M., Marinho, F., Mirkuzie, A. H., Misganaw, A. T., Monasta, L., Naik, P., Nomura, S., O'Brien, E. G., O'Halloran, J. K., Olana, L. T., Ostroff, S. M., Penberthy, L., Reiner Jr, R. C., Reinke, G., Ribeiro, A. L. P., Santomauro, D. F., Schmidt, M. I., Shaw, D. H., Sheena, B. S., Sholokhov, A., Skhvitaridze, N., Sorensen, R. J. D., Spurlock, E. E., Syailendrawati, R., Topor-Madry, R., Troeger, C. E., Walcott, R., Walker, A., Wiysonge, C. S., Worku, N. A., Zigler, B., Pigott, D. M., Naghavi, M., Mokdad, A. H., Lim, S. S., Hay, S. I., Gakidou, E., & Murray, C. J. L.
Affiliations
University of Washington (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
2022-04
Volume
399
Issue
10334
Pages
1513-1536
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4220867566
Cited by
2,069
References
32
Citations by year
2026: 161 · 2025: 258 · 2024: 473 · 2023: 787 · 2022: 385
FWCI
50.89
Type
journal article
Language
en
Update notices
erratum (2022-04-16)
Open access
Licence
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
Funders
  • National Science Foundation (2031096)
  • Bill and Melinda Gates Foundation
  • South African Medical Research Council
  • Ministry of Education, Culture, Sports, Science and Technology (/2016)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887, 88887.507149/2020-00, 2020-00)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (465518/2014‐1, 310679, 310679/2016‐8, 310679/2016-8 and 465518/2014-1, 2014-1, 2016‐8, PPM-00428-17, 2020-00, -8 and)
  • Medical Research Council
  • National Health and Medical Research Council (1121516, 310679, 2031096)
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
Keywords
excess mortality, COVID-19 pandemic, all-cause mortality, underreporting of deaths, LASSO, mortality prediction, seroprevalence, healthcare access and quality, India, low- and middle-income countries, uncertainty intervals
MeSH terms
COVID-19, SARS-CoV-2, Humans, Mortality, Global Health, Seroepidemiologic Studies, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02796-3
The paper
Wang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., Aravkin, A. Y., Bisignano, C., Barber, R. M., Alam, T., Fuller, J. E., May, E. A., Jones, D. P., Frisch, M. E., Abbafati, C., Adolph, C., Allorant, A., Amlag, J. O., Bang-Jensen, B., . . . Murray, C. J. L. (2022). Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. The Lancet. https://doi.org/10.1016/s0140-6736(21)02796-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.